SCHEMBL1962085

SCHEMBL1962085

O=C(O)c1ccc(-c2nn(-c3ccccc3)cc2Sc2ccc(Cl)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.61
KMT2A Q03164 6/20 0.61
MAPT P10636 3/20 0.61
FAAH O00519 3/20 0.61
KCNH2 Q12809 2/20 0.55
KDM4E B2RXH2 3/20 0.54
DRD2 P14416 1/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.54
AURKA O14965 5/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
PTGES O14684 2/20 0.51
RAB9A P51151 2/20 0.49
POLB P06746 2/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
GAA P10253 1/20 0.48
ALOX5 P09917 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1535178 0.91 FAAH (0.59) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL1961190 0.88 MAPT (0.57) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL1960741 0.88 FAAH (0.56) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL1535304 0.88 FAAH (0.56) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL15016140 0.85 FAAH (0.52) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL1964814 0.85 MAPT (0.54) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL15016239 0.85 FAAH (0.52) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL15016174 0.85 FAAH (0.60) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL1963570 0.85 MAPT (0.53) MEN1KMT2AMAPTFAAHKCNH2
SCHEMBL1535253 0.85 MAPT (0.53) MEN1KMT2AMAPTFAAHKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2299824-B1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2013-06-19 EP claimed
EP-2299824-B1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2013-06-19 EP disclosed
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HRH2 MEN1 3407/4885KMT2A 1541/4885MAPT 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.